Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
85 Cards in this Set
- Front
- Back
emesis is measured by...
|
measured by the number of vomiting or retching episodes after treatment
|
|
nausea definition
|
patient’s perception that emesis may occur; feeling "queasy"
|
|
what is the CTZ? (2)
|
Central site located in medulla
Originally believed to serve as final common pathway for processing all afferent impulses that can initiate emesis |
|
what is the central pattern generator? (2)
|
Loosely organized neuronal areas within medulla interact to coordinate emetic reflex
Involves variety of receptors more accurate model- not just ONE SPOT (with the CTZ) |
|
is there a final common pathway for nausea/vomiting
implications for medicating |
No final common pathway, so no single agent can be expected to provide complete coverage
|
|
how chemo induces nausea- via what transmitter (3)
|
chemo sends message to brain
5HT3 then message back to stomach = puke |
|
sites of action slide
|
---
|
|
nausea/vomiting pathway- peripheral receptors located where (what are the cells called)?
what do they release? |
enterochromaffin cells in stomach-->releases serotonin-->message goes to brain-->vomit/nausea
|
|
2 ways/pathways that chemo causes nausea
|
Chemotherapy causes localized serotonin (5-HT) release from entero-chromaffin cells
5-HT interacts with 5-HT3 receptors on vagal afferent nerves, projecting to dorsal vagal complex on dorsal brain stem Efferent fibers project from the dorsal vagal complex to central pattern generator Antineoplastics may also induce emesis through direct interaction with the AP |
|
2 areas in brain where vagal afferent nerves carrying emesis signal project to
|
nucleus tractus solitarius (NTS) & area postrema (AP)
|
|
3 receptors present in CNS that are associated with nausea/vomit
|
Neurokinin-1 (NK-1), 5-HT3, & dopamine-2 receptors are present here
|
|
anti emetics most effect when given...when?
|
Most effective when given prophylactically
PREVENT, PREVENT, PREVENT!!! |
|
general approach to administering anti-emesis for chemo (timing) (3)
|
Begin therapy at least 30 minutes prior to chemo
Administer around‐the‐clock until chemo is complete, & provide PRN agents for breakthrough N/V Provide patients with additional PRN anti‐emetics to take home after chemotherapy |
|
3 least sedating anti-emetics
|
Butyrophenones (haloperidol) , corticosteroids, and serotonin antagonists
|
|
EPS a risk from what 3 anti emetics
|
with phenothiazines 9compazine, promethazine), butyrophenones, and metoclopramide
|
|
Evaluate emetogenic potential & pattern of the chemo regimen: e.g. ...(2)
|
Can be additive, i.e. combination regimens vs. single agents
May be different on different days of treatment (e.g., highly on day 1 and moderately on days 2 and 3); antiemetics should be tailored accordingly |
|
5 types of CIV (vomiting)
|
acute- if multiple days of same drug- each day is considered acute
delayed anticipatory breakthrough refractory |
|
acute vs. delayed CIV- timing
|
acute- within first 24 hrs of receiving chemo
delayed- 24 hrs after & lasting up to 5 days |
|
breakthrough CIV- definition
|
occurs despite preventatives
|
|
4 drugs that commonly cause delayed CIV
|
cisplatin, cyclophosphamide, carboplatin & anthracyclines
(basically alkylating agents...platins...anthracyclins) |
|
refractory CIV- definition
|
occurs during subsequent cycles when antiemetic prophylaxis or rescue therapy has failed in earlier cycles (basically CIV that occurs no matter what you do)
|
|
2 MAJOR risk factors for emesis
|
EMETIC POTENTIAL OF DRUG (what drug are you giving)
DOSE OF MEDICATION |
|
6 (2 pt related, 4 hx related) risk factors for emesis
|
Female
Age < 50 High pretreatment expectation of nausea or history of previous chemo-induced N/V (CINV) History of low alcohol (high alcohol blunts your stomach rxn) consumption History of motion sickness History of morning sickness during pregnancy |
|
potential causes for nausea (8)
|
Partial or complete bowel obstruction
Vestibular dysfunction Brain metastases- red flag if they suddenly get nausea Electrolyte imbalance: hypercalcemia, hyperglycemia, hyponatremia Uremia Other drugs (opiates) Gastroparesis: disease (diabetes) or drug (vincristine and vinca alkaloids = constipation = backing up plumbing) Psychophysiologic: anxiety or anticipatory bottom line: many things that come into play and important to ID what is causing n/v |
|
emesis risk classifications (s anti emetic therapy) for chemo drugs (4)
|
High: >90% of emesis*
Moderate: 30 – 90% of emesis* Low: 10 – 30% of emesis* Minimal: <10% of emesis* |
|
3 IV drugs that we have to know that cause emesis- and their risk classifications
|
cisplatin- high emetic risk
etoposide- low risk bleomycin- minimal risk |
|
place to look for emesis risk for oral drugs
|
NCCN guidelines
|
|
combination therapy that is really high risk for emesis
|
AC combination (dox/cyclophosphamide)AC
|
|
emend MoA (2)
what receptors and where |
substance P/NK1 antagonist
NK-1 receptors distributed throughout GI tract & CNS, but antiemetic activity believed to have central site of action |
|
High risk & AC treatment
(how many days...what to give on each day) |
Day 1: 5-HT3, dexamethasone (dex) & NK1 antagonist (NK1-ra: Neurokinen 1 receptor antagonist)
Day 2 & 3: dexamethasone & NK1-ra Day 4: dexamethasone (optional) for delayed... |
|
moderate risk anti emetic regimen (how many days...what to give on each day)
|
Day 1: Palonosetron (any 5HT3 will work) & dex, Day 2 & 3: dex
|
|
low risk anti emetic regimen
|
dexamethasone 8 mg Day 1 only
|
|
minimal anti emetic regimen
|
no routine prophylaxis
|
|
when to try palonsetron (2)
|
try palonosetron if ondansetron doesn't work
or multiple days of therapy- idk is palonsetron dosed shorter? |
|
what if you follow guidelines for ASCO and they still puke
|
if you follow guidelines for anti emesis...and your pt still has it, bump them up a risk category and try that regimen next time
|
|
if combo chemo, how to determine risk category
|
administer anti-emetics appropriate for the agents of greatest emetic risk
|
|
Multiple, consecutive day chemo- how to determine risk and regimen for anti emesis
|
anti-emetics appropriate for the risk class of the regimen administered each day of treatment & for 2 days after
WHAT??? idk it sounded like you give the acute phase every day until it's done...then give dexa (delayed nausea ppx) after it's finished- ugh look this up |
|
radiation and n/v
what to give |
can cause n/v
give 5HT3 antagonists |
|
lower therapeutic index medications (6)
|
Metoclopramide
Butyrophenones: (haloperidol, droperidol) Phenothiazines (prochlorperazine) Cannabinoids (dronabinol , nabilone) Olanzapine Scopolamine patch |
|
lower therapeutic index meds are used for...(2)
NOT used for? |
Not appropriate first-choice antiemetics
Reserve for patients who are intolerant of or refractory to 5-HT3ra, NK1-ra, & dex (as add-ons?) Consider for rescue medication at home |
|
add on med of choice for anxiety induced
other med you can add as adjunctive therapy |
lorazepam
diphenhydramine |
|
Olanzapine pretty effective as
|
an adjuctive for delayed N/V
|
|
cannabinoids- 2
|
nabilone, dronabinol
|
|
dopamine antagonists- (3)
|
antipsychotics (prochlorperazine/olanzapine), metoclopramide
|
|
corticosteroid- 2
|
methylpred, dexamethasone
|
|
NK-1 blocker-
|
aprepitant
|
|
5HT3r antagonists- moa
|
Selectively antagonizes 5-HT binding to 5-HT3 receptors on vagal afferents
|
|
5HT3r properties (efficacy on acute vs dlayed)
|
Most effective class for preventing acute; little effect on delayed
|
|
AE of 5HT3a (4)
|
usually no AE but...
headache, constipation, transient rise of hepatic aminotransferase levels; QTC elongation can occur from electrolyte imbalances |
|
5HT3ar properties (interchangeability, dosing intervals, PO vs. IV)
|
Interchangeable at equivalent doses ***
Once-daily dose similar to multiple-daily dose *** PO equivalent to IV*** |
|
which 5HT3ar is CI for IV
|
Dolasetron contraindicated IV adm
|
|
Steroid of choice for n/v and why (2)
|
dexamethasone
most literature, crosses BBB |
|
corticosteroids- efficacy for acute/delayed
|
Effective for both acute & delayed- backbone for delayed emesis
|
|
dexamethasones- interaction with what drug potentially?
dose adjustment if it's part of antineoplastic regimen too? |
Potential interaction with aprep; no dose adjustment when constitute part of the antineoplastic regimen- though if dose is high enough...you don't have to add on top of it for emesis
|
|
oral vs IV name for NK1-antagonist
|
Aprepitant--> Oral version- more expensive, part D??
Fosaprepitant--> IV version- medicare A |
|
dosing difference between apreiptant and fosaprepitant
|
150 mg day 1 for IV (ONE DAY)
3 days for aprepitant (125 mg then 80 mg x 2) |
|
AE of aprepitant/fosaprepitant (6)
|
hiccoughs, HA, constipation/diarrhea, fatigue or asthenia, hypotension, dyspepsia
|
|
aprep/fosaprep- renal dosing adjustment?
|
No dosage adjustments are recommend for either end‐stage renal disease requiring hemodialysis or severe renal insufficiency
|
|
fosaprep/aprep- which phase will it treat of nausea/vomit?
|
CNS activity- DELAYED- toxins are gone- out of stomach- 5HT3 is for acute...
if it's CNS then it can help delayed |
|
metabolism of fosaprep/aprep (3)
|
Substrate of CYP3A4, but time of administration complications this
Administered for 3 days per cycle of chemotherapy, it is an inhibitor of the CYP3A4. Administered > 14 days it’s a potent inducer of both CYP3A4 and 2C9 |
|
any significant DDI with chemo drugs with aprep/fosaprep? (2) dose adjustments?
|
No significant interactions with chemo have been identified but...
Study showed trend toward increased risk of ifosfamide neurotoxicity No dose adjustments recommended |
|
regular drug DDIs with aprep/fosaprep (6)
|
oral contraceptives
warfarin dexamethasone midazolam CYP3A4 inhibitors CYP3A4 inducers |
|
aprep/fosaprep DDI with oral conraceptives
|
decreases efficacy; women of child‐bearing yrs should use alternative birth control
|
|
a/f DDI with warfarin and what you need to do
|
need INR checked 7‐10 days after aprepitant as there may be clinically significant decrease seen in INR
|
|
a/f DDI with dexamethasone
most significant with what route |
increased dexamethasone AUCs were seen in clinical trials; most significant for PO administration
|
|
a/f DDI with midazolam
|
increased AUC ...of midazolam?
|
|
3 CYP3A4 inhibitors
|
erythromycin, itraconazole, ketoconazole
|
|
3 CYP3A4 inducers
|
carbamazepine, phenytoin, and rifampin
|
|
3 meds you might see rx'ed for at home control of nausea (delayed)
indicate which is best/used most |
ondansetron- not that effectively used on a prn basis though...doesn't make sense to use in delayed nausea (which is what at home use is for)
metoclopramide in diabetic pt maybe or pancreatic cancer pt but prochlorperazine used the most for home rescue use/control of N/V |
|
GI syndrome: consteallation of sx (4)
|
Severe diarrhea, N/V, Anorexia, Abdominal cramping
|
|
CID- thought to be caused by what?
results in what? |
Thought to be caused by direct toxicity to epithelial cell lining of the GI tract leading
Results in watery stool unaffected by fasting |
|
4 worst offenders for CID
|
Fluorouracil (esp with high does leucovorin)
Methotrexate Cytarabine Stem cell transplant conditioning |
|
duration of therapy and effect on CID incidence
|
Continuous infusions carry greater risk than short IV infusion
|
|
chemo mechanism for CID- what type of diarrhea
|
Stimulation of active secretion more than affecting the absorptive capacity of the intestinal epithelium
|
|
sx of CID often associated with...(4)
|
Symptoms were often associated with severe dehydration, neutropenia, fever, and electrolyte imbalances
|
|
irinotecan CID- phasing
|
has early (during infusion) & late onset phase (several days/weeks later)
|
|
irinotecan Late onset (severe, potentially fatal) : type
how to treat |
secretory diarrhea
immediately treat with aggressive dosing of loperamide |
|
early onset component of irinotecan CID- mechanism
treat with what |
Cholinergic process: facial flushing, diaphoresis, “hypersecretion”, and abdominal cramping
Treat with atropine (scopolamine prophylaxis?) |
|
Management of uncomplicated mild to moderate diarrhea (non pharm) (3)
and pharm |
Stop all lactose-containing products and alcohol
Frequent small meals & push oral hydration (e.g., 8‐10 glasses of clear fluids) Instruct pts to record # of stools & any symptoms Loperamide- 2 tabs...then 1 tab after every loose stool. if exceed 4 tabs call dr |
|
if diarrhea resolves- what should pt do? when can they d/c loperamide?
|
Continue dietary modifications & gradually add solid foods
Patients can discontinue loperamide when diarrhea-free for at least 12 hours |
|
if CID persists for more than 24 hrs on loperamide...
|
increase loperamide to 2 mg Q 2 hrs & consider starting oral antibiotics for infection prophylaxis (increase dose)
|
|
if CID persists for more than 48 hrs on loperamide (24 hrs after starting high‐dose loperamide) (3)
|
Stop loperamide and start 2nd‐line antidiarrheal
Complete stool & blood work‐up (cdiff, toxins) replace fluids & electrolytes as needed |
|
4 2nd line anti diarrheals
|
octreotide 100 to 150 mcg SQ
tincture of opium 10 to 15 drops in water Q3‐4 hr paregoric 5 mL in water Q3‐4 hr budesonide |
|
what to do for pt with complicated diarrhea (5)
|
Admit to hospital for IV hydration and electrolyte replacement
give SC octreotide if severe dehydration and escalate dose until diarrhea controlled (up to 500 mg q8h) IV antibiotics as needed, e.g., fluoroquinolone, metronidazole Complete stool and blood work‐up d/c chemo til sx resolve-->consider reducing dose for next cycle |
|
complicated diarrhea definition
|
5 bowel mvmts in a 12 hr period
|